ad
  1. Home
  3. Stocks
  5. Medicamen Biotech Ltd. (MEDICAM)
M
MEDICAM
₹349.60
-1.95 (0.55%)

Medicamen Biotech Ltd. (MEDICAM) live share price today at NSE / BSE

25 August, 2025 18:07 | NSE : MEDICAM | BSE : 531146 | ISIN:INE646B01010

Overview
Charts
Results
News & Events

Expert Verdict for Medicamen Biotech Ltd. (MEDICAM) Share

View details
Today`s low
₹0.00
Today`s high
₹0.00
Today`s return
Medicamen Biotech Ltd. (MEDICAM) Share Price Today
Performance Of Medicamen Biotech Ltd. (MEDICAM) Share Today
Opening Price:352.00
Previous closing Price:351.55
Volume of Medicamen Biotech Ltd. (MEDICAM) share:23,903
Value of Share:349.60
Fundamental of Medicamen Biotech Ltd. (MEDICAM) Share Price
Market Capitalisation:474 Cr.
P/E Ratio:49.91
P/B Ratio:1.88
Sector P/E:43.55
EPS (TTM):7.00
Dividend Yield:0.29
14D - RSI:73.38
50 DMA:388.18
200 DMA:454.49

Note: The above data is mentioned as per the Medicamen Biotech Ltd. (MEDICAM) share price today.

Medicamen Biotech Ltd. (MEDICAM) Share Price Today At NSE

    • Live Medicamen Biotech Ltd. (MEDICAM) Share Price NSE India: ₹349.60
    • Previous Closing Price: ₹351.55
    • Open Price: ₹352.00
    • High: ₹355.00
    • Low: ₹346.15

Medicamen Biotech Ltd. (MEDICAM) Share Price Today At BSE

  • Live Medicamen Biotech Ltd. (MEDICAM) Share Price BSE India: ₹350.00
  • Previous Closing Price: ₹352.20
  • Open Price: ₹353.95
  • High: ₹354.35
  • Low: ₹346.15

Historical Price Of Medicamen Biotech Ltd. (MEDICAM) Share

The table below shows the variations in Medicamen Biotech Ltd. (MEDICAM) share price from October 2021 to August 2025.

Month & YearPrice (INR)Open Price (INR)High Price (INR)Low Price (INR)Volume (Cr.)Change %
October 2021₹563.95₹552.10₹574.30₹539.55₹10,8082.15
November 2021₹585.85₹540.00₹738.00₹540.00₹2,98,1698.49
December 2021₹887.60₹597.60₹1,019.80₹581.10₹18,58,80848.53
January 2022₹808.00₹898.90₹1,005.00₹767.00₹5,24,805-10.11
February 2022₹662.40₹820.00₹898.70₹585.00₹3,09,975-19.22
March 2022₹640.85₹669.00₹704.05₹594.00₹2,65,642-4.21
April 2022₹672.95₹648.05₹865.90₹641.05₹5,41,2563.84
May 2022₹652.15₹678.00₹812.70₹574.55₹4,58,485-3.81
June 2022₹669.45₹659.05₹729.00₹557.20₹2,55,2041.58
July 2022₹782.10₹669.45₹806.80₹650.10₹3,47,25816.83

Shareholding Pattern of Medicamen Biotech Ltd. (MEDICAM) Shares In Stock Market

The below depicted shareholding pattern is as per the Medicamen Biotech Ltd. (MEDICAM) Industries Ltd. Share Price Market of June 2025.

Promoters40.46%
Foreign Institutions0.00%
Retail and Others59.54%
Other Domestic Institutions0.00%
Mutual Funds0.00%
Don't Miss!!!
MEDICAMMedicamen Biotech Ltd.
CIPLACipla Ltd.
TORNTPHARMTorrent Pharmaceuticals Ltd.
DRREDDYDr. Reddy's Laboratories Ltd.
ABBOTINDIAAbbott India Ltd.
Medicamen Biotech Ltd. (MEDICAM) Share Background
Face Value10.00
ISININE646B01010
Market Lot1.00
InstrumentEQUITY
Should you invest in Medicamen Biotech Ltd. (MEDICAM) Industries Limited?
  • Every milestone results from a lot of hard work, effort, and making the correct decisions, but patience is essential.
  • Patience is the key to success in the share market, which is also important in attaining benefits on Medicamen Biotech Ltd. (MEDICAM) share price.
  • In terms of investment, the investor’s patience pays off with a high return, which is why long-term investors are the most successful.
  • Medicamen Biotech Ltd. (MEDICAM) Industries has produced a great return to the last year and is reaching new milestones daily; it has become the first Indian firm to attain a market capitalisation of 474 Cr.

    • Medicam FAQs

    Is Medicamen Biotech Ltd. a good stock to invest in?

    arrow

    Our expert verdict states that Medicamen Biotech Ltd. is in Sell zone for Short term and is in Sell zone for Long term.

    Should I buy Medicamen Biotech Ltd. share now?

    arrow

    As per our verdict, Medicamen Biotech Ltd. is in the Sell zone for Short term.

    Should I buy Medicamen Biotech Ltd. shares for the long term?

    arrow

    As per our verdict, Medicamen Biotech Ltd. is in Sell zone for Long term.

    What is Medicamen Biotech Ltd. share price today?

    arrow

    The Medicamen Biotech Ltd. share price today is 349.6.

    How to buy Medicamen Biotech Ltd. share?

    arrow

    You can buy Medicamen Biotech Ltd. shares on any demat broker by completing your KYC. Before buying any stock, check BUY/SELL/HOLD insights on the Univest App.

    What is the share price of Medicamen Biotech Ltd.?

    arrow

    The share price of Medicamen Biotech Ltd. is 349.6, please note that the price may vary on a real-time basis.

    What is the PE and PB ratio of Medicamen Biotech Ltd.?

    arrow

    PE ratio of Medicamen Biotech Ltd. is 49.91 and PB ratio of Medicamen Biotech Ltd. is 1.88.

    How’s PE of Medicamen Biotech Ltd. compared to its sector?

    arrow

    PE ratio of Medicamen Biotech Ltd. is 49.91 whereas the sector PE ratio is 43.55.

    What is the market cap of Medicamen Biotech Ltd.?

    arrow

    Medicamen Biotech Ltd.’s market cap is 474.

    What are today’s High and Low prices of Medicamen Biotech Ltd. ?

    arrow

    Today’s High of Medicamen Biotech Ltd. is 355.
    Today’s Low of Medicamen Biotech Ltd. is 346.15.

    icon

    100% Safe & Secure Platform.

    Univest encrypts all data and transactions to ensure a completely secure experience for our members.

    Copyright

    2025 Univest. All rights reserved. | Designed with ❤️ in India
    About Univest
    About: Univest is a cutting-edge stock market platform designed to help traders and investors maximize their returns with expert-driven advisory services and seamless trading execution. Whether you're a seasoned trader or just starting, Univest simplifies your investment journey with actionable trade recommendations, AI-powered portfolio insights, and a fully integrated brokerage experience. With Univest, you gain access to proven stock market advisory, offering expert trade ideas for stocks, futures, options, and commodities. Our one-click trade execution feature eliminates slippage, ensuring instant execution through our advisory-first brokerage. Smart portfolio management allows you to identify underperforming stocks, optimize your investments, and receive real-time alerts. Additionally, Univest provides seamless investment opportunities beyond stocks, including mutual funds, bonds, fixed deposits, and insurance (coming soon). Join over 40 lakh active investors who trust Univest to make informed and profitable trading decisions. Start investing smarter today! 🚀  
    Attention Investors : To ensure a smooth trading experience and prevent unauthorized transactions, investors must update their mobile number and email ID with their stockbroker or depository participant. As per regulatory requirements, investors are required to pay a stipulated amount as an upfront margin for trading in the Cash/FO segment. We encourage all investors to regularly check their securities in the Consolidated Account Statement (CAS) issued by depository to verify their holdings.Always verify alerts and transaction details received directly from the exchange or NSDL before proceeding with any trades. Please do not make payments through unverified email links, WhatsApp, or SMS. Always trade through a registered stockbroker and verify all details before making financial decisions.
     
    Disclaimer: Investments in the securities market are subject to market risks. Please read all related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. For more disclaimer /disclosure, visit https://univest.in/stock-broker or Univest App.We collect and use your contact information for legitimate business purposes, including providing updates on our products and services. We do not sell or rent your contact information to third parties. By submitting your details, you authorize us to contact you via Call/SMS, even if you are registered under DND. This authorization remains valid for 12 months.For grievances, please contact us at hello@unibrokers.in .
     
    Univest Stock Broking Disclosures
    Univest Stock Broking Private Limited - SEBI Reg. No. INZ000317437 (Stock Broker), NSE TM Code: 90392, BSE TM Code: 6866, MCX TM Code: 57290 and ICCL- Self Clearing Member Code: 6866, SEBI Reg. No. IN-DP-779-2024 (Participant), NSDL DP ID: IN304748.
     Risk Disclosures on Derivatives
    1. 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
    2. On an average, loss makers registered net trading loss close to ₹ 50,000
    3. Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
    4. Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
    Attention Investors: As per NSE circular dated July 6, 2022: https://nsearchives.nseindia.com/content/circulars/INSP52900.pdf, BSE circular dated July 6, 2022: https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20220706-55, MCX circular dated July 11, 2022: https://www.mcxindia.com/docs/default-source/circulars/english/2022/july/circular-418-2022.pdf?sfvrsn=9401991_0, investors are cautioned to abstain them from dealing in any schemes of unauthorised collective investments/portfolio management, indicative/ guaranteed/fixed returns / payments etc. 
    Investors are further cautioned to avoid practices like:
    a. Sharing 
    i) trading credentials – login id and passwords including OTPs.
    ii) trading strategies,
    iii) position details.
    b. Trading in leveraged products /derivatives like Options without proper understanding, which could lead to losses.
    c. Writing/ selling options or trading in option strategies based on tips, without basic knowledge and understanding of the product and its risks.
    d. Dealing in unsolicited tips through platforms like Whatsapp, Telegram, Instagram, YouTube, Facebook, SMS, calls, etc.
    e. Trading / Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.
     Kindly read the Advisory Guidelines For Investors as prescribed by the Exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client’s assets: https://nsearchives.nseindia.com/content/circulars/INSP49434.pdf
    Kindly, read the advisory as prescribed by the Exchange with reference to their circular: NSE/ISC/51035 dated January 14, 2022 regarding Updation of mandatory KYC fields by March 31, 2022: https://www.nseindia.com/resources/exchange-communication-circulars# 
    Attention Investors: Prevent unauthorised transactions in your Demat account by updating your mobile number with your depository participant. Receive alerts on your registered mobile number for debit and other important transactions in your Demat account directly from NSDL on the same day. Prevent unauthorised transactions in your Trading account by updating your mobile numbers/email addresses with your stock brokers. Receive information on your transactions directly from the Exchange on your mobile/email at the end of the day. Issued in the interest of investors. KYC is a one-time exercise while dealing in securities markets - once KYC is done through a SEBI-registered intermediary (Broker, DP), you need not undergo the same process again when you approach another intermediary. As a business, we don’t give stock tips and have not authorised anyone to trade on behalf of others. If you find anyone claiming to be part of Univest Stock Broking Private Limited and offering such services, please send us an email at hello@unibrokers.in
    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.
    Update your email ID and mobile number with your stockbroker/depository participant and receive an OTP directly from the depository on your registered email ID and/or mobile number. Check your securities/mutual funds/bonds in the Consolidated Account Statement (CAS) issued by NSDL every month.
    Attention Investors: SEBI has established an Online Dispute Resolution Portal (ODR Portal) for resolving disputes in the Indian Securities Market. This circular streamlines the existing dispute resolution mechanism, offering online conciliation and arbitration, benefiting investors and listed companies https://www.sebi.gov.in/legal/circulars/jul-2023/online-resolution-of-disputes-in-the- indian-securities-market_74794.html. ODR portal for Investors - https://smartodr.in/login.
    Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
    Quick Links: SEBI | NSE | BSE | MCX | Account Opening Process | Policies and Procedures | Register and Track Complaint | SEBI scores | SMART ODR | NSDL e-Voting | USCNBA | Account Closure | ContactUs 
    Market Indices: Nifty 50 | Nifty 100 | Sensex | Nifty PSU Bank | Nifty Auto | Nifty 200 | Nifty 500 | Nifty Alpha 50 | Nifty Commodities | Nifty Consumptions | Nifty CPSE | Nifty Div Opps 50 | Nifty Energy | Nifty Growsect 15 | Nifty High Beta 50 | Nifty Fin Services | Nifty Infra | Nifty IT | Nifty Largemid 200 | NIfty Low Volatility 50 | Nifty Mid Cap 100
    Screeners: Top Gainers | Top Losers | 52 Week High | 52 Week Low | FIIs Holding Change | DIIs Holding Change | Fundamentally Strong | Upcoming Dividends | Daily Fresh Breakout | Weekly Breakout | Nearing Breakout | Oversold Stocks | Volume Shockers | Golden Crossover | Short Term | Long Term | Top Stocks Result to Watch | Share Market Today
    Sharks: Rakesh Jhunjhunwala | Radhakishan Damani | Azim Premji | Mukul Agrawal | Ashish Dhawan | Ashish kacholia | Anil Goel | Bhavook Tripathi | Vijay Kishanlal kedia  | Enam Securities | Vistra ITCL | Punjab National Bank | The Oriental Insurance Company | Jm Financial | GOVT. Of Singapore | EuroPacific Growth Fund | Govt. Pension Fund GLobal
    Trending Stocks: ONGC | Zomato | Adani Enterprises | Reliance Industries | IOCL | Bajaj Auto |  Tata Motors | IRFC | IRCTC | Jindal Steel | HUDCO | BHEL | BEL | SBI | Kotak Bank | HDFC | Airtel | Coal India | LIC | Amber Enterprises | Kalyan Jewellers | Titan | JIO Fin Services | TCS | Infosys | Tech Mahindra | HCL | DLF | Godrej | ITC | Hindustan Unilever | NTPC | Power Finance Corp | Deepak Nitrite | Pidilite | Hero Moto Corp | ATUL | Maruti Suzuki | IndusInd Bank | CDSL | Indigo | L&T | RVNL | Grasim | MRF | CEAT | V-Guard
    Trending Blogs: EPS Formula | DE Ratio | ROE | PB Ratio | Dividend Yield | PE Ratio | Penny Stocks | Demat Account | Fundamentally Strong Penny Stocks | Fundamentally Strong Stocks In BSE | Debt Free Penny Stocks Below 1 Rupee
    General
    arrow down